Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
IKT
$1.94
-2.02%
IKT
· Inhibikase Therapeutics, Inc.
$1.94
-0.04 (-2.02%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$270.70M
Shares
139.54M
Volume · Oct 7
444.05K
Avg daily vol (3M)
662.66K
All webcasts
Earnings call · FY2025 Q2
Inhibikase Therapeutics, Inc. (IKT) Q2 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$0
Diluted EPS
-$0.11
Net income
-$9.92M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2025 · complete as-filed document